Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Lancet. HIV|September 23, 2024
Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysisLinxuan Wu, David Kaftan, Rachel Wittenauer, et al.JMIR Formative Research|March 14, 2023
Integration of a Digital Health Intervention Into Immunization Clinic Workflows in Kenya: Qualitative, Realist Evaluation of Technology UsabilitySamantha B Dolan, Rachel Wittenauer, Jessica C Shearer, et al.JMIR Formative Research|March 17, 2023
Time Utilization Among Immunization Clinics Using an Electronic Immunization Registry (Part 2): Time and Motion Study of Modified User WorkflowsSamantha B Dolan, Rachel Wittenauer, Anne Njoroge, et al.BMJ Open|December 16, 2020
Antimicrobial use across six referral hospitals in Tanzania: a point prevalence surveyJeremiah Seni, Siana G Mapunjo, Rachel Wittenauer, et al.Journal of the American Pharmacists Association : Japha|February 13, 2025
Characterizing pharmacy deserts and designing a model to minimize inequities in pharmacy distribution in VirginiaJoseph Boyle, Rachel Wittenauer, Shreya Ramella, et al.Frontiers in Pharmacology|November 16, 2020
National Consumption of Antimicrobials in Tanzania: 2017-2019Romuald Mbwasi, Siana Mapunjo, Rachel Wittenauer, et al.Antibiotics (Basel, Switzerland)|February 25, 2022
Point Prevalence Survey of Antibiotic Use across 13 Hospitals in UgandaReuben Kiggundu, Rachel Wittenauer, J P Waswa, et al.Health Affairs (Project Hope)|July 7, 2026
Access To Community Pharmacies Associated With Reduced Racial And Ethnic Disparities In Use Of Prescription Drugs, 2010-19Maitreyi Sahu, Tyler D Wagner, Drew DeJarnatt, et al.The Lancet. HIV|February 1, 2024
Impact of HIV self-testing for oral pre-exposure prophylaxis scale-up on drug resistance and HIV outcomes in western Kenya: a modelling studySarah N Cox, Linxuan Wu, Rachel Wittenauer, et al.Vaccine|July 8, 2023
Value profile for respiratory syncytial virus vaccines and monoclonal antibodiesJessica A Fleming, Ranju Baral, Deborah Higgins, et al.Pageof 2